GSK-3β is abundant in the central nervous system (Lee et al., 2006; Leroy et al., 2007), and regulating GSK-3β activity is considered to be one of the important preventive strategies for neurodegenerative diseases. This evidence concerns the gene GSK3B and neurodegenerative disease.